"Comedy post of the day TJ."
LOL
I don't know about that - I wasn't going to mention ALL those posts from KNL holders that I thought took the comedy, or bad taste award, but you would have to agree the "tasteless" post of the day came from a KNL poster who tried to give us a "reds under the beds" history of dealing with the Russians - Post #:22207640. I decided to ignore those posts and take them for what they were - tasteless, appalling scaremongering. But why am I not surprised you would find them acceptable.
I would be equally appalled if an MNS poster penned a post raising Thyssenkrupp's past "history".
My post, if you read, discusses the importance of finding a market across all products - flake sizes/grades...."This MOU deals with finding a "possible" market for 22 ktpa Super Jumbo Flake and 77 ktpa Jumbo Flake" and the word was "POSSIBLE", due to the early nature of negotiations - MOU.
No one knows the quantity - or the price - or all the fine print involved in this MOU. However, I doubt Rosatom would contemplate "project financing" if they were buying a "thimble" full of Super Jumbo & Jumbo flake.
- Forums
- ASX - By Stock
- MNS
- Incase you missed it amid all the hype.
Incase you missed it amid all the hype., page-49
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
MNS (ASX) Chart |
Day chart unavailable